Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis.
about
Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.Prognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort.Subcutaneous and intravenous belimumab in the treatment of systemic lupus erythematosus: a review of data on subcutaneous and intravenous administration.Osteoporotic fractures in patients with systemic lupus erythematosus and end stage renal disease.Current and Emerging Therapies for Lupus Nephritis.Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective.Update on Lupus Nephritis.Advances in the care of children with lupus nephritis.Childhood lupus nephritis: 12 years of experience from a developing country's perspective.Economic evaluation of lupus nephritis in the Systemic Lupus International Collaborating Clinics inception cohort using a multistate model approach.circHLA-C Plays an Important Role in Lupus Nephritis by Sponging miR-150.Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy.The relationship between cell apoptosis dysfunction and FEN1 E160D mutation in lupus nephritis patients.Methodological Quality of Studies of Endstage Renal Disease in Lupus Nephritis, 1970 to 2015.New Perspectives in Rheumatology: May You Live in Interesting Times: Challenges and Opportunities in Lupus Research.Impact of Diabetes Mellitus on the Risk of End-Stage Renal Disease in Patients with Systemic Lupus Erythematosus.Serum albumin at 1 year predicts long-term renal outcome in lupus nephritis
P2860
Q33806541-69CFBEA3-46FD-4E49-A3B8-3C7087680CE4Q36234766-33EBF673-5717-438E-9D80-198E507D21C1Q38605480-3FDFCFD1-6EA6-408A-A1F5-0E813EA1FA66Q38771730-245966E6-2D83-4193-8E8A-CEA72BA5AF2EQ38855495-C381920F-AE18-414D-A48D-D416710A44C4Q38877052-B785473B-7F52-4694-AB6E-61E9BEC013E2Q39002132-45E2B838-C1EE-4709-AEB2-83D991625033Q39010807-E8C77FD2-2A8F-4985-ADED-6A4F8B1B563AQ47164898-D3AEA77A-E8F6-485E-B94E-211203C946BAQ47385774-444DCE93-4A8A-4373-920A-60FDAD15128BQ49257416-7C4C0020-3CED-41F9-9F96-5DB3817E34C8Q49475768-EC9EC379-F90E-44E7-83BD-8EA7CA038BFBQ49850797-FFC22637-9D09-445F-A3DF-C08A90FF99D4Q50891276-1F82E37F-28A9-4EBA-9B0E-4FAE51AF46D1Q53383480-7637343E-DCE0-476C-AB3D-EB8B123C41DDQ53694839-2F706805-75C6-43C7-B540-D934B01E4542Q58764611-3FEEEF06-1112-471B-A985-AAF2EAAC0D2B
P2860
Risk of End-Stage Renal Disease in Patients With Lupus Nephritis, 1971-2015: A Systematic Review and Bayesian Meta-Analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk of End-Stage Renal Diseas ...... ew and Bayesian Meta-Analysis.
@en
Risk of End-Stage Renal Diseas ...... ew and Bayesian Meta-Analysis.
@nl
type
label
Risk of End-Stage Renal Diseas ...... ew and Bayesian Meta-Analysis.
@en
Risk of End-Stage Renal Diseas ...... ew and Bayesian Meta-Analysis.
@nl
prefLabel
Risk of End-Stage Renal Diseas ...... ew and Bayesian Meta-Analysis.
@en
Risk of End-Stage Renal Diseas ...... ew and Bayesian Meta-Analysis.
@nl
P2860
P356
P1476
Risk of End-Stage Renal Diseas ...... iew and Bayesian Meta-Analysis
@en
P2093
Michael M Ward
P2860
P304
P356
10.1002/ART.39594
P577
2016-06-01T00:00:00Z